A Roll-over Study With Rilpivirine for Human Immunodeficiency Virus Type 1 (HIV-1) Infected Participants Who Participated in Rilpivirine Pediatric Studies
Clinical trial NCT02494986 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02494986
- Sponsor
- Janssen Sciences Ireland UC
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-06
- Primary completion
- 2026-08-18
- Enrollment
- 48
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.